Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 EUR | +0.47% | -4.93% | -57.34% |
May. 03 | Crossject: praised for extended agreement on Zepizure | CF |
May. 02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
Evolution of the average Target Price on Crossject
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALCJ Stock
- Consensus Crossject